Mynvax

About:

Mynvax is an Indian-based biotech startup that develops next-generation vaccines for influenza.

Website: http://mynvax.com/

Top Investors: Accel, LetsVenture, 1Crowd, Kotak Alternate Asset Managers, Nimesh Kampani

Description:

Mynvax is an Indian-based biotech startup that develops next-generation vaccines for influenza. In addition, the technology allows for very rapid, large-scale, and low-cost production of vaccines that could potentially be used to protect people when there is a pandemic. Mynvax, which was incubated at the Indian Institute of Science, was founded in 2017 by Raghavan Varadarajan and Gautham Nadig.